MedPath

Medhya Effect of Suvarnaprashana on Intelligence Quotient

Phase 2
Registration Number
CTRI/2022/09/045563
Lead Sponsor
PGIASR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children with intelligence quotient 80 to 110.

children who were physically and mentally healthy.

Exclusion Criteria

Individual below 6year and above 15 year.

Children with systemic disorder/chronic disorders.

Children with learning disorders.

Children with gross brain damage causing mental retardation.

Children with any genetic disorder.

H/O hypersensitivity to any of the trial drug any of its ingredients.

Any contraindications mentioned for Lehan karma in Kashyap Samhita.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the medhya effect of suvarnaprashana in enhancing the Intelligence quotientTimepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
To evaluate the medhya effect of suvarnaprashana in enhancing the Intelligence quotient <br/ ><br>Signs and symptoms will be observedTimepoint: 45 days <br/ ><br>other sign and symptoms will be observed
© Copyright 2025. All Rights Reserved by MedPath